Clinical trial
Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial With Medico-economic Evaluation of the Treatment.
NCT03790293 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial With Medico-economic Evaluation of the Treatment.
- Lead sponsor
- University Hospital, Rouen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 17, 2018
- Completion date
- April 19, 2019
- Enrollment
- 80 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.